Tempest Therapeutics
TPST
86 hedge funds and large institutions have $796M invested in Tempest Therapeutics in 2015 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 37 increasing their positions, 12 reducing their positions, and 13 closing their positions.
453% more call options, than puts
Call options by funds: $9.99M | Put options by funds: $1.8M
208% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 12
108% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 13
18% more funds holding
Funds holding: 73 → 86 (+13)
7% less capital invested
Capital invested by funds: $854M → $796M (-$57.5M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$94.4M |
| 2 |
Jennison Associates
New York
|
+$69.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$65.1M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$51.1M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$50.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DVC
Deer VII & Co
Larchmont,
New York
|
-$94.7M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$12.9M |
| 3 |
DM
Deerfield Management
New York
|
-$9.99M |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$4.33M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$3.73M |
TPST Hedge Fund Activity: Q1 2015 in Review
86 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q1 2015, worth a combined $796M — down 6.7% from $854M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new TPST positions and 13 closed out — a net gain of 14 holders — while 37 added to existing stakes and 12 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $94.4M. The largest seller was Deer VII & Co, cutting an estimated $94.7M.
- 86 institutional investors held Tempest Therapeutics (TPST) as of Q1 2015, up from 73 in Q4 2014.
- Funds reported $796M of Tempest Therapeutics stock for Q1 2015, down 6.7% quarter-over-quarter.
- 27 funds opened new Tempest Therapeutics positions in Q1 2015 and 13 closed out, a net change of +14 holders.
- The largest Tempest Therapeutics buyer in Q1 2015 was Sabby Management, an estimated $94.4M added.
- The largest Tempest Therapeutics seller in Q1 2015 was Deer VII & Co, an estimated $94.7M sold.
Based on aggregated 13F filings for Q1 2015.